A clinical trial of a structurally unique neuroleptic (SU-23397).
D000328:Adult; D001572:Benzofurans / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013141:Spiro Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D001572:Benzofurans; D013141:Spiro Compounds; D014149:Tranquilizing Agents; C010829:8((2,3-dihydro-5-methoxy-2-benzofuranyl)- methyl)-1-phenyl-1,3,8-triazospiro(4,5)decan-4-one